Our Investments for Changing Healthcare

Rahul Agarwal

Managing Director

Rahul has 18 years of private equity and corporate finance advisory experience across deals in Asia and US. At Quadria, he is responsible for investments, portfolio management, and divestment for South Asia portfolio. Previously, he served at Religare Global Asset Management, Evolvence India Fund, and EY. He also serves as a Community Leader – Healthcare, Pharma and Healthtech at Aspire Impact Future Project. He is a recipient of 40 under 40 Alternative Investment Professionals award for 2020 in India. He is a rank holder Chartered Accountant (CA) and an MBA graduate from IIM Lucknow. Beyond work, he likes to keep fit via cycling and squash. He also mentors MBA students on career guidance and networking opportunities.

Ong Si Keat

Senior Associate

Ong Si Keat has over 10 years of experience in private equity, venture capital, and capital markets. Prior to Quadria Capital, he held roles with Dyman Asia Private Equity, Kumpulan Modal Perdana, and Capital Dynamics Group in Malaysia.

Mr. Ong holds a Bachelor of Engineering (Mechatronics) from Monash University and is a CFA charterholder.

Gabriel Teo

Associate

Gabriel Teo has over 2 years of investment banking experience primarily in M&A transactions. Prior to joining Quadria Capital, he was at Credit Suisse as an Associate in the Investment Banking & Capital Markets Division, covering Consumer, Retail & Healthcare.

Mr. Teo holds a Bachelor of Business Management and Bachelor of Science (Economics) from the Singapore Management University, graduating Summa Cum Laude.

Toan Nguyen

Associate

Toan Nguyen has over 3 years of investment banking experience, focusing on M&A and ECM transactions. Prior to joining Quadria Capital, he was an Investment Banking Analyst at BDA Partners and Viet Capital Securities. Mr. Nguyen holds a Bachelor of Science (Mathematical Economics) from the University of Richmond.

Vikrant Parashar

Strategic Associate

Vikrant is an Associate in the Managing Partners’ office and works on fundraising/investor relations, investments, and industry advocacy. He joined Quadria in Jun’2024 with 8 years of experience. Previously, he worked at Encube Ethicals, Hindalco Industries (Aditya Birla Group), Reliance Industries, and EY. At Encube, the global leader in topical pharmaceuticals and a Quadria portfolio company, he was EA (Strategy) to MD and focussed on business strategy and M&A. He is an MBA graduate from FLAME University, the philanthropic venture of ENAM Holdings. Beyond work, he likes reading nonfiction and doing meditation.

Shivani Sahai

Head of ESG and Impact

Shivani has 12 years of experience in sustainability and impact strategy. She joined Quadria in Jan’2022 and leads the firm’s efforts for ESG and impact outcomes at portfolio companies. She is also responsible for articulating the impact thesis and implementing the Impact Management Framework in investment due-diligence process. Previously, she worked at KPMG, EY, and PwC. She holds an MBA in Business Sustainability from TERI University and is a BCom graduate from Jesus and Mary College, University of Delhi. Beyond work, she likes travelling and hiking.

Carina Tai

Assistant Manager

Carina Tai has 4 years of experience in the ESG and sustainability field. Ms. Tai has provided ESG advisory for businesses in Southeast Asia, Hong Kong, and Mainland China. Prior to joining Quadria, she worked in Deloitte’s Sustainability and Climate Advisory and Assurance team, as well as EY’s Climate Change and Sustainability team.

Ms. Tai holds a Bachelor of Arts in Conservation from the University of Hong Kong.

Hank Klakurka

Director

Hank Klakurka has over 40 years of experience in the global pharmaceuticals industry and has extensive experience in both branded and generic pharmaceuticals. He is the former CEO of Merck Generics Group and played a key role in its sale to US-based Mylan for US$6.7B in 2007. He grew the Merck Generics business from approximately €900m to €1.8B since joining the company in 2001 as head of its Americas Region. He was promoted to CEO of the group in 2003. Prior to joining Merck, Mr. Klakurka held various leadership positions with major pharma companies including Astra AB, Schering-Plough, Johnson & Johnson and Apotex. In addition to advising Private Equity funds on Healthcare investments, he currently is President of Hank Klakurka and Associates Inc., advising Pharma firms on strategic matters in the USA and Canada. In the SEA region, he currently serves on the Board of Directors for SOHO Global Health.

He holds a B.S. from the University of Toronto and has completed Merck’s business programs at Insead, Kellogg, HKUST and IMD.

K Srivatsan

Director

K Srivatsan has over 30 years of experience in India and Southeast Asia covering pharmaceuticals, vaccines, and healthcare, including primary and dental care, radiology, pathology, and hospitals. He has cross-functional knowledge across commercial and technical functions, including acquisitions and divestitures. Srivatsan has held leadership positions in both multinational corporations and large promoter-led businesses.

He holds a Bachelor’s in Commerce and professional certifications in Cost and Works Accounting and Company Secretarial Works.

Gerald Ng

Managing Director

Gerald Ng has over 16 years of experience in investment banking and fundraising. Mr. Ng is responsible for Quadria Capital’s investor relations and fundraising activities. Prior to joining Quadria, he held roles at Northstar Advisors, EQT Partners, Citigroup, Deutsche Bank, and ABN AMRO.

Mr. Ng holds a Bachelor of Science from the University of Michigan – Ann Arbor and a Master’s degree from Stanford University.